News
Attorneys
Practice Areas
The IP Strategy Summit: Biotech & Pharma – Boston
presented by CenterForce
Bryan D. Zerhusen, Ph.D., Partner and Chair, Life Sciences Practice, will speak on the panel, "Strategic Portfolio Management: Balancing Cost, Coverage, and Value in Life Sciences" at the IP Strategy Summit: Biotech & Pharma - Boston on May 14, 2025.
In the competitive biopharma industry, adopting a strategic approach to patent portfolio management is crucial for success. Bryan will be part of a panel discussion that will provide actionable insights on optimizing global patent coverage, balancing costs with R&D budgets, and aligning patent strategies with broader business objectives. Experts will also explore methods to identify high-value assets, streamline portfolio maintenance, and evaluate ROI using advanced tools and techniques. The panel will also discuss aligning R&D investments with long-term business goals through effective patent evaluation, pruning underperforming patents to reduce maintenance costs and maximize portfolio value, managing global patent coverage while controlling expenses and addressing complexities, and leveraging innovative tools and technologies to enhance portfolio management efficiency.
Bryan counsels innovators in the chemical and life science industries in all aspects of domestic and foreign patent preparation and prosecution. Chair of the firm's Life Sciences Practice Group, Bryan’s clients include solo inventors, academic institutions, foreign law firms, venture firms, as well as companies ranging from start-ups to global corporations in the medical biotechnology, agricultural biotechnology, diagnostic, chemical, pharmaceutical, medical device and healthcare sectors.
The IP Strategy Summit: Biotech & Pharma – Boston gathers industry leaders tackling the evolving challenges of intellectual property in biotech and pharma. As companies face increasing pressures from regulatory shifts, rising R&D costs, and market competition, securing and optimizing IP assets has never been more critical. This summit will provide essential insights into safeguarding biopharma innovations, refining patent strategies, and navigating global prosecution complexities. Experts will explore key topics such as trade secret protection, precision patenting, strategic portfolio management, and monetizing IP assets through licensing and collaborations.
